Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

There's no better drive-thru porch-sipper than McDonald's Sweet Tea, but you can brew a copycat version with plenty of sugar ...

Shares in Wegovy maker Novo Nordisk continued to slide on Wednesday as analysts warned of persistent competition from copycat ...

Furthermore, the governments called out Scattered Spider's use of readily available malware tools like Ave Maria (aka Warzone ...

“NCIS: Tony & Ziva” star Cote de Pablo reveals why she and Michael Weatherly didn't want an intimacy coordinator Pete Buttigieg says Democratic Party’s attachment to two words handed Trump the White ...

Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

McDonald’s slow return of its Snack Wrap paved the way for one of the strangest battles in the ongoing fast-food war.

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

LONDON (Reuters) -Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales growth and sliding share price. He first will need to win ...